{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:50:44Z","timestamp":1776340244060,"version":"3.51.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangdong Provincial Clinical Research Center for Digestive Diseases","award":["2020B1111170004"],"award-info":[{"award-number":["2020B1111170004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the value of hyperechoic mesenteric fat (HMF) detected by preoperative intestinal ultrasound (IUS) in predicting early postoperative recurrence (EPR) in patients with Crohn\u2019s disease (CD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      This retrospective study included 124 CD patients who underwent I-stage intestinal resection. Based on 1-year postoperative recurrence, patients were stratified into EPR (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200959) and non-EPR (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200965) groups. Clinical parameters (such as smoking history, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), immunosuppressive therapy) and IUS parameters (such as bowel wall thickness (BWT), HMF, abscess\/fistula) were compared. Univariate and multivariate logistic regression identified EPR predictors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      EPR occurred in 59 patients (47.6%) during the 1-year follow-up. Significant differences (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) were observed between EPR and non-EPR groups for clinical factors (smoking history, elevated preoperative CRP\/ESR, postoperative immunosuppression) and IUS parameters (HMF, BWT, and abscess\/fistula). HMF demonstrated superior discriminative capacity for EPR prediction (area under the curve (AUC)\u2009=\u20090.808, 95% confidence interval (CI): 0.728\u20130.873) vs BWT (AUC\u2009=\u20090.618,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) and abscess\/fistula (AUC\u2009=\u20090.599,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Univariate analysis identified CRP, ESR, colonic disease, immunosuppression, HMF, abscess\/fistula, and BWT as candidate predictors (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), with multivariate analysis confirming HMF as an independent predictor (adjusted odds ratio (OR)\u2009=\u200918.810, 95% CI: 6.459\u201354.775;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Preoperative IUS-detected HMF may serve as a valuable predictor for assessing EPR risk in patients with CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical relevance statement<\/jats:title>\n                    <jats:p>Preoperative IUS identification of HMF provides a practical, non-invasive biomarker that enables radiologists to critically improve risk stratification for EPR in CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>EPR poses a significant clinical challenge in the management of CD.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>HMF detected on preoperative IUS is a strong, independent predictor for EPR,\u00a0with superior predictive performance compared to other established IUS parameters.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Assessing HMF provides a valuable, non-invasive imaging biomarker for preoperative risk stratification.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-026-02251-2","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:01:01Z","timestamp":1776337261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperechoic mesenteric fat on preoperative intestinal ultrasound predicts early postoperative recurrence in Crohn\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Zhuohua","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5224-008X","authenticated-orcid":false,"given":"Guangjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2251_CR1","doi-asserted-by":"publisher","unstructured":"Fasulo E, D'amico F, Osorio L et al (2023) The management of postoperative recurrence in Crohn\u2019s disease. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13010119","DOI":"10.3390\/jcm13010119"},{"key":"2251_CR2","doi-asserted-by":"publisher","unstructured":"Lee KE, Cantrell S, Shen B et al (2022) Post-operative prevention and monitoring of Crohn\u2019s disease recurrence. Gastroenterol Rep (Oxf). https:\/\/doi.org\/10.1093\/gastro\/goac070","DOI":"10.1093\/gastro\/goac070"},{"key":"2251_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/ecco-jcc\/jjad186","volume":"18","author":"C Hern\u00e1ndez-Rocha","year":"2024","unstructured":"Hern\u00e1ndez-Rocha C, Walshe M, Birch S et al (2024) Clinical predictors of early and late endoscopic recurrence following ileocolonic resection in Crohn\u2019s disease. J Crohns Colitis 18:615\u2013627. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad186","journal-title":"J Crohns Colitis"},{"key":"2251_CR4","doi-asserted-by":"publisher","unstructured":"Dragoni G, Allocca M, Myrelid P et al (2023) Results of the eighth scientific workshop of ECCO: diagnosing postoperative recurrence of Crohn\u2019s disease after an ileocolonic resection with ileocolonic anastomosis. J Crohns Colitis. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad055","DOI":"10.1093\/ecco-jcc\/jjad055"},{"key":"2251_CR5","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3390\/biomedicines12112434","volume":"12","author":"AO Olteanu","year":"2024","unstructured":"Olteanu AO, Klimko A, Tieranu EN et al (2024) Managing Crohn\u2019s disease postoperative recurrence beyond prophylaxis: a comprehensive review with meta-analysis. Biomedicines 12:2434. https:\/\/doi.org\/10.3390\/biomedicines12112434","journal-title":"Biomedicines"},{"key":"2251_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/ecco-jcc\/jjaa216","volume":"15","author":"KL Novak","year":"2021","unstructured":"Novak KL, Nylund K, Maaser C et al (2021) Expert consensus on optimal acquisition and development of the International Bowel Ultrasound Segmental Activity Score [IBUSSAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn\u2019s Disease. J Crohns Colitis 15:609\u2013616. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa216","journal-title":"J Crohns Colitis"},{"key":"2251_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/gutjnl-2011-300370","volume":"61","author":"L Peyrin-Biroulet","year":"2012","unstructured":"Peyrin-Biroulet L, Gonzalez F, Dubuquoy L et al (2012) Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn\u2019s disease. Gut 61:78\u201385. https:\/\/doi.org\/10.1136\/gutjnl-2011-300370","journal-title":"Gut"},{"key":"2251_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/ueg2.12349","volume":"10","author":"Y Yin","year":"2022","unstructured":"Yin Y, Xie Y, Ge W et al (2022) Creeping fat formation and interaction with intestinal disease in Crohn\u2019s disease. United European Gastroenterol J 10:1077\u20131084. https:\/\/doi.org\/10.1002\/ueg2.12349","journal-title":"United European Gastroenterol J"},{"key":"2251_CR9","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/ibd\/izad095","volume":"29","author":"EP Tsounis","year":"2023","unstructured":"Tsounis EP, Aggeletopoulou I, Mouzaki A et al (2023) Creeping fat in the pathogenesis of Crohn\u2019s disease: An orchestrator or a silent bystander? Inflamm Bowel Dis 29:1826\u20131836. https:\/\/doi.org\/10.1093\/ibd\/izad095","journal-title":"Inflamm Bowel Dis"},{"key":"2251_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomoll\u00f3n","year":"2017","unstructured":"Gomoll\u00f3n F, Dignass A, Annese V et al (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis 11:3\u201325. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw168","journal-title":"J Crohns Colitis"},{"key":"2251_CR11","doi-asserted-by":"publisher","first-page":"111144","DOI":"10.1016\/j.ejrad.2023.111144","volume":"168","author":"J Zhou","year":"2023","unstructured":"Zhou J, Li W, Guo M et al (2023) Mesenteric creeping fat index defined by CT enterography is associated with early postoperative recurrence in patients with Crohn\u2019s disease. Eur J Radiol 168:111144. https:\/\/doi.org\/10.1016\/j.ejrad.2023.111144","journal-title":"Eur J Radiol"},{"key":"2251_CR12","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/apt.12743","volume":"39","author":"GR Jones","year":"2014","unstructured":"Jones GR, Kennedy NA, Lees CW et al (2014) Systematic review: the use of thiopurines or anti-TNFin post-operative Crohn\u2019s disease maintenance\u2014progress and prospects. Aliment Pharmacol Ther 39:1253\u20131265. https:\/\/doi.org\/10.1111\/apt.12743","journal-title":"Aliment Pharmacol Ther"},{"key":"2251_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A et al (2021) STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160:1570\u20131583. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.031","journal-title":"Gastroenterology"},{"key":"2251_CR14","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s40265-023-01916-2","volume":"83","author":"JP Gisbert","year":"2023","unstructured":"Gisbert JP, Chaparro M (2023) Anti-TNF agents and new biological agents (vedolizumab and ustekinumab) in the prevention and treatment of postoperative recurrence after surgery in Crohn\u2019s disease. Drugs 83:1179\u20131205. https:\/\/doi.org\/10.1007\/s40265-023-01916-2","journal-title":"Drugs"},{"key":"2251_CR15","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1080\/14712598.2021.1964469","volume":"21","author":"C Liu","year":"2021","unstructured":"Liu C, Li N, Zhan S et al (2021) Anti-TNF\u03b1 agents in preventing the postoperative recurrence of Crohn\u2019s disease: Do they still play a role in the biological era? Expert Opin Biol Ther 21:1509\u20131524. https:\/\/doi.org\/10.1080\/14712598.2021.1964469","journal-title":"Expert Opin Biol Ther"},{"key":"2251_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cell.2020.09.009","volume":"183","author":"CWY Ha","year":"2020","unstructured":"Ha CWY, Martin A, Sepich-Poore GD et al (2020) Translocation of viable gut microbiota to mesenteric adipose drives formation of creeping fat in humans. Cell 183:666\u2013683.e17. https:\/\/doi.org\/10.1016\/j.cell.2020.09.009","journal-title":"Cell"},{"key":"2251_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/DCR.0000000000002287","volume":"65","author":"SD Holubar","year":"2022","unstructured":"Holubar SD, Gunter RL, Click BH et al (2022) Mesenteric excision and exclusion for ileocolic Crohn\u2019s Disease: feasibility and safety of an innovative, combined surgical approach with extended mesenteric excision and Kono-S anastomosis. Dis Colon Rectum 65:5. https:\/\/doi.org\/10.1097\/DCR.0000000000002287","journal-title":"Dis Colon Rectum"},{"key":"2251_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/SLA.0000000000003821","volume":"272","author":"G Luglio","year":"2020","unstructured":"Luglio G, Rispo A, Imperatore N et al (2020) Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn\u2019s disease: the SuPREMe-CDstudy\u2014a randomized clinical trial. Ann Surg 272:210\u2013217. https:\/\/doi.org\/10.1097\/SLA.0000000000003821","journal-title":"Ann Surg"},{"key":"2251_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1053\/j.gastro.2024.12.028","volume":"168","author":"M Duan","year":"2025","unstructured":"Duan M, Liu W, Coffey JC et al (2025) Postoperative endoscopic outcomes in the MESOCOLIC trial investigating mesenteric-based surgery for Crohn\u2019s disease. Gastroenterology 168:987\u2013990.e5. https:\/\/doi.org\/10.1053\/j.gastro.2024.12.028","journal-title":"Gastroenterology"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02251-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-026-02251-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02251-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:01:02Z","timestamp":1776337262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-026-02251-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1186\/s13244-026-02251-2","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional ethics review board at the Sixth Affiliated Hospital, Sun Yat-sen University (no. 2024ZSLYEC-337). Due to the retrospective design of the study and the use of de-identified data, informed consent from individual participants was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The requirement for written consent forms was waived owing to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}